Filings Intelligence
Company filings profile · CIK 0001398733

Aquestive Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Aquestive Therapeutics, Inc. (AQST): 22 filings in the last 90 days vs 33 in the prior 90 (filing-velocity cooling ↓ · 0.67×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.

Material 8-K events — Aquestive Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 17, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Aug 11, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits↗
Aug 10, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Jun 10, 2026Item 5.07; Financial Statements and Exhibits↗
May 13, 2026Entry into a Material Agreement; Termination of a Material Agreement; Results of Operations (earnings); Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits↗

Watch Aquestive Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Watch this company →See a sample alert

Insider transactions (Form 4 / 3 / 5)

FiledForm
Sep 16, 20264↗
Sep 11, 20264↗
Sep 10, 20264↗
Sep 9, 20264↗
Sep 8, 20264↗
Aug 18, 20264↗
Aug 17, 20264↗
Jul 17, 20264↗
Jun 24, 20264↗
Jun 16, 20264↗
Jun 12, 20264↗
Jun 12, 20264↗
Jun 12, 20264↗
Jun 12, 20264↗
Jun 12, 20264↗
Jun 12, 20264↗
Jun 9, 20264↗
May 19, 20264↗
May 18, 20264↗
May 18, 20264↗

Recent filings

FiledFormDetail
Sep 17, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Sep 16, 20264 PRIMARY DOCUMENT ↗
Sep 15, 2026144 ↗
Sep 11, 20264 PRIMARY DOCUMENT ↗
Sep 10, 20264 PRIMARY DOCUMENT ↗
Sep 9, 20264 PRIMARY DOCUMENT ↗
Sep 9, 2026144 ↗
Sep 8, 20264 PRIMARY DOCUMENT ↗
Aug 18, 20264 PRIMARY DOCUMENT ↗
Aug 17, 20264 PRIMARY DOCUMENT ↗
Aug 17, 2026144 ↗
Aug 11, 202610-Q 10-Q ↗
Aug 11, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 10, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Jul 27, 2026SCHEDULE 13G/A ↗
Jul 17, 20264 PRIMARY DOCUMENT ↗
Jul 15, 2026144 ↗
Jul 9, 2026424B3 424B3 ↗
Jul 8, 2026EFFECT Item ; Item ; Item ↗
Jun 26, 2026S-3 S-3 ↗
Jun 24, 20264 PRIMARY DOCUMENT ↗
Jun 23, 2026144 ↗
Jun 16, 20264 PRIMARY DOCUMENT ↗
Jun 15, 2026144 ↗
Jun 12, 20264 PRIMARY DOCUMENT ↗
Jun 12, 20264 PRIMARY DOCUMENT ↗
Jun 12, 20264 PRIMARY DOCUMENT ↗
Jun 12, 20264 PRIMARY DOCUMENT ↗
Jun 12, 20264 PRIMARY DOCUMENT ↗
Jun 12, 20264 PRIMARY DOCUMENT ↗
Jun 10, 20268-K Item 5.07; Financial Statements and Exhibits ↗
Jun 9, 20264 PRIMARY DOCUMENT ↗
May 19, 20264 PRIMARY DOCUMENT ↗
May 18, 20264 PRIMARY DOCUMENT ↗
May 18, 20264 PRIMARY DOCUMENT ↗
May 15, 2026144 ↗
May 13, 202610-Q 10-Q ↗
May 13, 20268-K Entry into a Material Agreement; Termination of a Material Agreement; Results of Operations (earnings); Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits ↗
May 11, 20264 PRIMARY DOCUMENT ↗
May 7, 20264 PRIMARY DOCUMENT ↗